Title:
|
Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study
|
Author:
|
Guiriguet, Carolina; Pera, Guillem; Castells, Antoni; Toran, Pere; Grau, Jaume; Rivero, Irene; Buron, Andrea; Macià, Francesc; Vela-Vallespín, Carmen; Vilarrubí-Estrella, Mercedes; Marzo-Castillejo, Mercè
|
Other authors:
|
[Guiriguet C] Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Mataró, Spain. Departament de Medicina Familiar, Institut Català de la Salut, Barcelona, Spain. Centre d’Atenció Primària (CAP) Gòtic, Institut Català de la Salut, Barcelona, Spain. [Pera G, Castells A] Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Mataró, Spain. [Castells A] Servei de Gastroenterologia, Hospital Clínic, Universitat de Barcelona, Barcelona. Spain. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain. [Grau J] Servei de Medicina Preventiva, Departament de Salut Pública, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain. Departament d’Epidemiologia, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. [Rivero I] Departament de Medicina Familiar, Institut Català de la Salut, Barcelona, Spain. [Burón A, Macià F] Servei de Medicina Preventiva I Epidemiologia, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain. [Vela-Vallespín C, Vilarrubí-Estrella M] Departament de Medicina Familiar, Institut Català de la Salut, Santa Coloma de Gramenet, Spain. [Marzo-Castillejo M] Unitat de Suport a la Recerca Metropolitana Sud, Institut Universitari d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Cornellà de Llobregat, Spain; IDIAP Jordi Gol |
Abstract:
|
Colorectal neoplasm; Early detection of cancer; Mass screening |
Abstract:
|
Neoplàsia colorrectal; Detecció precoç del càncer; Cribratge massiu |
Abstract:
|
Neoplasia colorrectal; Detección temprana de cáncer; Cribaje masivo |
Abstract:
|
BACKGROUND There is controversy regarding how comorbidity impacts on colorectal cancer screening, especially in the context of organised programmes. The aim of this study is to assess the effect of comorbidities on participation in the Barcelona population-based colorectal cancer screening programme (BCCSP). METHODS Cross-sectional study carried out in ten primary care centres involved in the BCCSP. Individuals aged 50 to 69, at average risk of colorectal cancer, who were invited to participate in the first round of the faecal immunochemical test-based BCCSP were included (2011-2012). The main variable was participation in the BCCSP. Comorbidity was assessed by clinical risk group status. Other adjusting variables were age, sex, socioeconomic deprivation, visits to primary care, smoking, alcohol consumption and body mass index. Logistic regression models were used to test the association between participation in the programme and potential explanatory variables. The results were given as incidence rate ratios (IRR) and their 95% confidence intervals (CI). RESULTS Of the 36,208 individuals included, 17,404 (48%) participated in the BCCSP. Participation was statistically significantly higher in women, individuals aged 60 to 64, patients with intermediate socioeconomic deprivation, and patients with more medical visits. There was a higher rate of current smoking, high-risk alcohol intake, obesity and individuals in the highest comorbidity categories in the non-participation group. In the adjusted analysis, only individuals with multiple minor chronic diseases were more likely to participate in the BCCSP (IRR 1.14; 95% CI [1.06 to 1.22]; p < 0.001). In contrast, having three or more dominant chronic diseases was associated with lower participation in the screening programme (IRR 0.76; 95% CI [0.65 to 0.89]; p = 0.001). CONCLUSIONS Having three or more dominant chronic diseases, was associated with lower participation in a faecal immunochemical test-based colorectal cancer screening programme, whereas individuals with multiple minor chronic diseases were more likely to participate. Further research is needed to explore comorbidity as a cause of non-participation in colorectal cancer screening programmes and which individuals could benefit most from colorectal cancer screening. |
Subject(s):
|
-Còlon - Càncer -Recte - Càncer -Càncer - Detecció precoç -DISEASES::Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms -ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT::Diagnosis::Early Diagnosis::Early Detection of Cancer -HEALTH CARE::Health Services Administration::Patient Care Management::Comprehensive Health Care::Primary Health Care -ENFERMEDADES::Neoplasias::Neoplasias por Localización::Neoplasias del Sistema Digestivo::Neoplasias Gastrointestinales::Neoplasias Intestinales::Neoplasias Colorrectales -TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::diagnóstico precoz::detección precoz del cáncer -ATENCIÓN DE SALUD::administración de los servicios de salud::gestión de la atención al paciente::atención integral de salud::atención primaria de la salud |
Rights:
|
Atribución-NoComercial-SinDerivadas 3.0 España
http://creativecommons.org/licenses/by-nc-nd/3.0/es/
|
Document type:
|
Article Article - Published version |
Published by:
|
BioMed Central
|
Share:
|
|